Survival after lumpectomy and mastectomy for early stage invasive breast cancer: The effect of age and hormone receptor status

Department of Surgery, Duke University Comprehensive Cancer Center, Durham, North Carolina. .
Cancer (Impact Factor: 4.89). 09/2013; 119(7). DOI: 10.1002/cncr.27795
Source: PubMed


Randomized clinical trials (RCT) have demonstrated equivalent survival for breast-conserving therapy with radiation (BCT) and mastectomy for early-stage breast cancer. A large, population-based series of women who underwent BCT or mastectomy was studied to observe whether outcomes of RCT were achieved in the general population, and whether survival differed by surgery type when stratified by age and hormone receptor (HR) status.

Information was obtained regarding all women diagnosed in the state of California with stage I or II breast cancer between 1990 and 2004, who were treated with either BCT or mastectomy and followed for vital status through December 2009. Cox proportional hazards modeling was used to compare overall survival (OS) and disease-specific survival (DSS) between BCT and mastectomy groups. Analyses were stratified by age group (< 50 years and ≥ 50 years) and tumor HR status.

A total of 112,154 women fulfilled eligibility criteria. Women undergoing BCT had improved OS and DSS compared with women with mastectomy (adjusted hazard ratio for OS entire cohort = 0.81, 95% confidence interval [CI] = 0.80-0.83). The DSS benefit with BCT compared with mastectomy was greater among women age ≥ 50 with HR-positive disease (hazard ratio = 0.86, 95% CI = 0.82-0.91) than among women age < 50 with HR-negative disease (hazard ratio = 0.88, 95% CI = 0.79-0.98); however, this trend was seen among all subgroups analyzed.

Among patients with early stage breast cancer, BCT was associated with improved DSS. These data provide confidence that BCT remains an effective alternative to mastectomy for early stage disease regardless of age or HR status.

Download full-text


Available from: Christina A Clarke, Mar 06, 2015
  • Source
    • "lumpectomy) followed by radiation is considered the recommended surgical approach over mastectomy for women diagnosed with early breast cancer. A recent study of 112,154 women diagnosed with stage I or II breast cancer compared lumpectomy/radiation (55%) versus mastectomy (45%) procedures and found that the survival rate for women who received lumpectomy/radiation was more favorable regardless of age or cancer type [1]. Successful breast conserving surgery is directly dependent on complete removal of the tumor mass with clear margins [2]. "

    Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XI; 02/2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose. In November 2009, the U.S. Preventative Service Task Force (USPSTF) revised their breast cancer screening guidelines. We evaluated the pattern of screening subsequent to the altered guidelines in a cohort of women. Methods. Our database was queried for the following variables: age, race, method of diagnosis, mass palpability, screening frequency, histology, and stage. Statistical analyses were performed using Pearson's chi-square and Fisher's exact tests. Results. 1112 women were diagnosed with breast cancer from January 2010 to 2012. The median age at diagnosis was 60 years. Most cancers were detected on mammography (61%). The majority of patients had invasive ductal carcinoma (59%), stage 0 (23%), and stage 1 (50%) cancers. The frequency of screening did not change significantly over time (P = 0.30). However, nonregular screeners had an increased risk of being diagnosed with later stage breast cancer (P < 0.001) and were more likely to present with a palpable mass compared to regular screeners (56% versus 21%; P < 0.001). Conclusions. In our study, screening behavior did not significantly change in the years following the USPSTF guidelines. These results suggest that women who are not screened annually are at increased risk of a delay in breast cancer diagnosis, which may impact treatment options and outcomes.
    09/2013; 2013(1):327567. DOI:10.1155/2013/327567
  • [Show abstract] [Hide abstract]
    ABSTRACT: An angular domain spectroscopic imaging system was built and validated using fresh ex vivo breast tissue samples (~ 2 mm thick). The hyperspectral system consisted of a halogen lamp, collimation optics, scanning stage with controller, a silicon micro-machined micro-channel array, and a pushbroom spectral imager. As a proof of concept, spectral data cubes acquired from tissue samples were input into principal component analysis and Mahalanobis discriminant analysis to differentiate between spectral signatures of breast tumor and normal tissue. It is proposed that the results from training sets can be used to construct a set of classifiers to enable tumor detection in samples representative of the surgical margins.
Show more